Clinical Trial Update: Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating umbilical cord tissue-derived mesenchymal stem cells for rheumatoid arthritis across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Umbilical cord tissue-derived mesenchymal stem cells

Snippet

Sponsor: Translational Biosciences | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: UNKNOWN